Syndax Pharmaceuticals logo

Syndax Pharmaceuticals

ID: 5290495

A pharmaceutical company that develops therapies targeting solid and hematological cancer tumors

3

Funding Rounds

$65.6m

Money raised

Overview

A pharmaceutical company that develops therapies targeting solid and hematological cancer tumors

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding

Funding series

Funding Series Analysis

The company Syndax Pharmaceuticals has raised a total of $65.6m in funding over 3 rounds.

Key Insights:

  • Syndax Pharmaceuticals Corporate funding round Funding Round 2020: $30m
  • Syndax Pharmaceuticals Series B round: $26.6m
  • Syndax Pharmaceuticals Series A round: $9m

Industries

Syndax Pharmaceuticals is active in the following industries: